Bohai Pharmaceuticals Group, Inc. Reports 37.2% Increase in Revenue and 54.6% Growth in Net Income for Fiscal 2011  
9/29/2011 10:31:24 AM

NEW YORK and YANTAI, China, Sept. 29, 2011 (GLOBE NEWSWIRE) -- Bohai Pharmaceuticals Group, Inc. (OTCBB:BOPH) (OTCQB:BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of modernized traditional Chinese medicine (TCM) in China, today reported financial results for the twelve months ended June 30, 2011.